Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is multiple myeloma?
Multiple myeloma is a cancer of plasma cells — the immune cells in the bone marrow that normally make antibodies to fight infection. In myeloma, abnormal plasma cells multiply, crowd the marrow, weaken the bones, and produce a faulty protein that can harm the kidneys. Because it involves the marrow throughout the body, myeloma is treated with medicines rather than surgery, and it tends to be a long-term, manageable disease: while not usually curable today, it can be controlled for many years through periods of remission and treatment. Radiation has a valued, focused role — it is one of the fastest, most effective ways to relieve pain from a bone lesion or to strengthen a bone at risk of fracture.
The main types
Doctors group multiple myeloma by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Active (symptomatic) multiple myeloma | Myeloma causing problems — bone damage, anemia, high calcium, or kidney injury — that needs treatment now. |
| Smoldering myeloma | An early, silent stage with myeloma cells present but no organ damage yet; often watched closely rather than treated immediately. |
| Solitary plasmacytoma | A single tumor of plasma cells in a bone or soft tissue, without widespread marrow disease — often treated and frequently controlled with radiation alone. |
Staging, in plain terms
Multiple myeloma is not staged with the TNM system. Instead it uses the Revised International Staging System (R-ISS), which combines simple blood markers (beta-2 microglobulin and albumin), a marker of cell turnover (LDH), and genetic features of the myeloma cells to sort patients into stages I-III that predict outlook and guide how intensively to treat.
| Revised International Staging System (R-ISS) | What it generally means |
|---|---|
| Stage I | Favorable blood markers and genetics — the most favorable group, often with excellent long-term control. |
| Stage II | An intermediate group between stages I and III. |
| Stage III | Higher-risk markers or genetics, indicating more aggressive disease that may need more intensive therapy. |
| Smoldering / MGUS (precursors) | Earlier conditions — a precursor protein finding (MGUS) or smoldering myeloma — that are monitored and treated only if they progress. |
The standard of care
Multiple Myeloma is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Combination drug therapy
Modern myeloma treatment uses combinations of three or four drugs — including proteasome inhibitors, immunomodulators, antibodies, and steroids — to drive the disease into deep remission.
Stem-cell transplant
An autologous (self) stem-cell transplant after high-dose chemotherapy deepens and prolongs remission for eligible patients, often followed by maintenance therapy.
Immunotherapy
Antibody drugs, bispecific antibodies, and CAR-T cell therapy now offer powerful options, especially for myeloma that returns after earlier treatment.
Radiation therapy
Focused radiation rapidly relieves pain from a bone lesion, treats a plasmacytoma, prevents or stabilizes a fracture, or eases pressure on the spinal cord.
How radiation treatment works
Radiation uses focused high-energy x-rays to damage the DNA of myeloma cells so they stop growing and the lesion shrinks. Myeloma cells are quite sensitive to radiation, which is why even modest, well-tolerated doses can relieve bone pain quickly — often within days to a couple of weeks. Advanced planning concentrates the dose on the affected bone while sparing the marrow elsewhere and nearby organs. Treatments are painless and brief, given over a small number of sessions. Side effects are usually mild and depend on the area treated, such as temporary fatigue or local skin or digestive changes that settle afterward.
The main ways radiation is delivered for multiple myeloma:
Palliative bone radiation
A few precise, low-dose treatments to a painful bone lesion relieve pain quickly and effectively — often one of the most reliable ways to restore comfort in myeloma.
Radiation for solitary plasmacytoma
A single plasma-cell tumor in bone or soft tissue is often treated with radiation alone, which can control it long-term and sometimes cure it.
Emergency / stabilizing radiation
Used urgently to relieve spinal-cord compression from a vertebral lesion, or to strengthen a bone at high risk of breaking, protecting mobility and function.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Four-drug combinations deepen remission: Adding a CD38 antibody (daratumumab) to standard three-drug regimens produced deeper, longer remissions for newly diagnosed myeloma, raising the standard of care.[1]
GRIFFIN and PERSEUS trials
CAR-T and bispecific antibodies: Immune therapies that redirect the body's T-cells against myeloma achieve strong responses in disease that has returned after multiple prior treatments.[2]
KarMMa and MajesTEC-1 trials, NEJM
Radiation for rapid pain control: Short courses of focused radiation reliably relieve painful myeloma bone lesions and treat solitary plasmacytomas, remaining a valuable, well-tolerated tool alongside drug therapy.[3]
Myeloma palliative radiation guidelines and series
Common questions
Can multiple myeloma be cured? For most people it is not yet considered curable, but it is very treatable — modern drug combinations and transplant control it for many years, often through repeated remissions, and new immune therapies keep extending that. A solitary plasmacytoma can sometimes be cured with radiation.
Why would I need radiation if myeloma is everywhere in the marrow? Medicines treat the disease throughout the body, but radiation is unmatched for a specific job — quickly relieving pain from a particular bone lesion, treating a single plasmacytoma, or stabilizing a bone or the spine. It complements, rather than replaces, drug therapy.
How fast does radiation relieve bone pain? Often quite quickly — many people notice meaningful pain relief within days to a couple of weeks of starting a short course of focused radiation, which can also reduce the need for pain medication.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.